Novel Local Radiomic Bayesian Classifiers for Non-Invasive Prediction of MGMT Methylation Status in Glioblastoma

• URL: http://arxiv.org/abs/2112.03259v1
• Date: Tue, 30 Nov 2021 04:53:23 GMT
• Title: Novel Local Radiomic Bayesian Classifiers for Non-Invasive Prediction of MGMT Methylation Status in Glioblastoma
• Authors: Mihir Rao
• Abstract summary: Expression of the O6-methylguanine-DNA-methyltransferase (MGMT) gene in glioblastoma tumor tissue is of clinical importance. Currently, MGMT methylation is determined through an invasive brain biopsy and subsequent genetic analysis of the extracted tumor tissue. We present novel Bayesian classifiers that make probabilistic predictions of MGMT methylation status based on radiomic features extracted from FLAIR-sequence magnetic resonance imagery (MRIs)
• Score: 0.0
• License: http://creativecommons.org/licenses/by/4.0/
• Abstract: Glioblastoma, an aggressive brain cancer, is amongst the most lethal of all cancers. Expression of the O6-methylguanine-DNA-methyltransferase (MGMT) gene in glioblastoma tumor tissue is of clinical importance as it has a significant effect on the efficacy of Temozolomide, the primary chemotherapy treatment administered to glioblastoma patients. Currently, MGMT methylation is determined through an invasive brain biopsy and subsequent genetic analysis of the extracted tumor tissue. In this work, we present novel Bayesian classifiers that make probabilistic predictions of MGMT methylation status based on radiomic features extracted from FLAIR-sequence magnetic resonance imagery (MRIs). We implement local radiomic techniques to produce radiomic activation maps and analyze MRIs for the MGMT biomarker based on statistical features of raw voxel-intensities. We demonstrate the ability for simple Bayesian classifiers to provide a boost in predictive performance when modelling local radiomic data rather than global features. The presented techniques provide a non-invasive MRI-based approach to determining MGMT methylation status in glioblastoma patients.

Related papers

• MRI Radiomics for IDH Genotype Prediction in Glioblastoma Diagnosis [0.0]
  This paper reviews the recent development in the oncological use of MRI radiomic features. It focuses on the identification of the isocitrate dehydrogenase (IDH) mutation status, which is an important biomarker for the diagnosis of glioblastoma and grade IV astrocytoma.
  arXiv  Detail & Related papers  (2024-09-23T20:34:49Z)
• Using Multiparametric MRI with Optimized Synthetic Correlated Diffusion Imaging to Enhance Breast Cancer Pathologic Complete Response Prediction [71.91773485443125]
  Neoadjuvant chemotherapy has recently gained popularity as a promising treatment strategy for breast cancer. The current process to recommend neoadjuvant chemotherapy relies on the subjective evaluation of medical experts. This research investigates the application of optimized CDI$s$ to enhance breast cancer pathologic complete response prediction.
  arXiv  Detail & Related papers  (2024-05-13T15:40:56Z)
• Cross-modality Guidance-aided Multi-modal Learning with Dual Attention for MRI Brain Tumor Grading [47.50733518140625]
  Brain tumor represents one of the most fatal cancers around the world, and is very common in children and the elderly. We propose a novel cross-modality guidance-aided multi-modal learning with dual attention for addressing the task of MRI brain tumor grading.
  arXiv  Detail & Related papers  (2024-01-17T07:54:49Z)
• MGMT promoter methylation status prediction using MRI scans? An extensive experimental evaluation of deep learning models [0.0]
  We employ deep learning models to predict the methylation status of the MGMT promoter in glioblastoma tumors using MRI scans. Our results show no correlation between these models' performance to assure the accuracy and reliability of deep learning systems in cancer diagnosis.
  arXiv  Detail & Related papers  (2023-04-03T07:55:42Z)
• Artificial-intelligence-based molecular classification of diffuse gliomas using rapid, label-free optical imaging [59.79875531898648]
  DeepGlioma is an artificial-intelligence-based diagnostic screening system. DeepGlioma can predict the molecular alterations used by the World Health Organization to define the adult-type diffuse glioma taxonomy.
  arXiv  Detail & Related papers  (2023-03-23T18:50:18Z)
• Generating counterfactual explanations of tumor spatial proteomes to discover effective strategies for enhancing immune infiltration [44.99833362998488]
  The tumor microenvironment (TME) significantly impacts cancer prognosis due to its immune composition. Here, we formulate T-cell infiltration prediction as a self-supervised machine learning problem. We apply our framework to melanoma, colorectal cancer liver metastases, and breast tumor data, discovering perturbations predicted to support T-cell infiltration.
  arXiv  Detail & Related papers  (2022-11-08T05:46:02Z)
• Artificial Intelligence Solution for Effective Treatment Planning for Glioblastoma Patients [0.0]
  Glioblastomas are the most common malignant brain tumors in adults. Approximately 200000 people die each year from Glioblastoma in the world. Glioblastoma patients have a median survival of 12 months with optimal therapy and about 4 months without treatment.
  arXiv  Detail & Related papers  (2022-03-09T22:29:48Z)
• Learned super resolution ultrasound for improved breast lesion characterization [52.77024349608834]
  Super resolution ultrasound localization microscopy enables imaging of the microvasculature at the capillary level. In this work we use a deep neural network architecture that makes effective use of signal structure to address these challenges. By leveraging our trained network, the microvasculature structure is recovered in a short time, without prior PSF knowledge, and without requiring separability of the UCAs.
  arXiv  Detail & Related papers  (2021-07-12T09:04:20Z)
• Comparison of Machine Learning Classifiers to Predict Patient Survival and Genetics of GBM: Towards a Standardized Model for Clinical Implementation [44.02622933605018]
  Radiomic models have been shown to outperform clinical data for outcome prediction in glioblastoma (GBM) We aimed to compare nine machine learning classifiers to predict overall survival (OS), isocitrate dehydrogenase (IDH) mutation, O-6-methylguanine-DNA-methyltransferase (MGMT) promoter methylation, epidermal growth factor receptor (EGFR) VII amplification and Ki-67 expression in GBM patients. xGB obtained maximum accuracy for OS (74.5%), AB for IDH mutation (88%), MGMT methylation (71,7%), Ki-67 expression (86,6%), and EGFR amplification (81,
  arXiv  Detail & Related papers  (2021-02-10T15:10:37Z)
• Radiogenomics of Glioblastoma: Identification of Radiomics associated with Molecular Subtypes [13.21715837712657]
  Glioblastoma is the most malignant type of central nervous system tumor. Subtypes of GBM are predicted with an average accuracy of 79% utilizing radiomics and accuracy over 90% utilizing gene expression profiles.
  arXiv  Detail & Related papers  (2020-10-27T05:31:56Z)

This list is automatically generated from the titles and abstracts of the papers in this site.

This site does not guarantee the quality of this site (including all information) and is not responsible for any consequences.